Correlation Between Werewolf Therapeutics and Merus BV
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and Merus BV, you can compare the effects of market volatilities on Werewolf Therapeutics and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Merus BV.
Diversification Opportunities for Werewolf Therapeutics and Merus BV
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Werewolf and Merus is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Merus BV go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and Merus BV
Given the investment horizon of 90 days Werewolf Therapeutics is expected to under-perform the Merus BV. In addition to that, Werewolf Therapeutics is 1.3 times more volatile than Merus BV. It trades about -0.05 of its total potential returns per unit of risk. Merus BV is currently generating about 0.17 per unit of volatility. If you would invest 4,040 in Merus BV on November 28, 2024 and sell it today you would earn a total of 400.00 from holding Merus BV or generate 9.9% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 95.45% |
Values | Daily Returns |
Werewolf Therapeutics vs. Merus BV
Performance |
Timeline |
Werewolf Therapeutics |
Merus BV |
Werewolf Therapeutics and Merus BV Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Werewolf Therapeutics and Merus BV
The main advantage of trading using opposite Werewolf Therapeutics and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
Merus BV vs. Anebulo Pharmaceuticals | Merus BV vs. Adagene | Merus BV vs. Acrivon Therapeutics, Common | Merus BV vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |